Market Newsdesk

November 17, 2020 6:23 pm

Aaron’s Holdings Sets Record and Closing Date for Spin-Off of the Aaron’s Business

Company Establishes Record Date of November 27, 2020

Anticipates Closing Spin-Off on November 30, 2020

PR Newswire

ATLANTA, Nov. 17, 2020 /PRNewswire/ — Aaron’s Holdings Company, Inc. (NYSE: AAN) (the “Company”), a leading omnichannel provider of lease-purchase solutions, today announced that its Board of Directors has established November 27, 2020 as the record date and November 30, 2020 as the anticipated closing date for the distribution of the Aaron’s Business segment to the Company’s shareholders.

Following the spin-off transaction, the Company will be renamed PROG Holdings, Inc and will trade on the New York Stock Exchange under the new symbol “PRG”. The spun-off company that will hold the Aaron’s Business segment will be named The Aaron’s Company, Inc. (The Aaron’s Company), and its common stock will trade on the New York Stock Exchange under the symbol “AAN”.

Additional Details of the Distribution

The separation will be completed through a pro rata dividend of The Aaron’s Company common stock to Company shareholders of record as of the close of business on the record date. Each Company shareholder as of the record date will receive one (1) share of common stock of The Aaron’s Company for every two (2) shares of Company common stock held by such shareholder on the record date. Shareholders will receive cash in lieu of any fractional shares that they would otherwise receive in the distribution.

The distribution does not require shareholder approval, nor is any shareholder action necessary to receive shares in the distribution of common stock of The Aaron’s Company. Shareholders who hold Company common stock as of the record date will receive shares in book-entry form and no physical share certificates of The Aaron’s Company will be issued.

The Aaron’s Company’s Registration Statement on Form 10, as amended, including an Information Statement describing the spin-off, the Aaron’s Business, certain risks of owning common stock of The Aaron’s Company and other details regarding the separation and distribution has been filed with the U.S. Securities and Exchange Commission and notice of internet availability of the information statement will be mailed to the Company’s shareholders as of the record date and posted to the investor relations section of the Company’s website.

The spin-off has been structured to qualify as a tax-free distribution to Company shareholders and the Company for U.S. federal income tax purposes, except with respect to cash received in lieu of fractional shares. Company shareholders should consult with their tax advisors with respect to the U.S. federal, state, local and foreign tax consequences of the spin-off.

Beginning on November 25, 2020, and continuing until the occurrence of the distribution, the Company expects that Company common stock will trade in two markets on the NYSE: in the “regular-way” market under the symbol “AAN” and under the current name, “Aaron’s Holdings Company, Inc.”, and in the “ex-distribution” market under the symbol “PRG WI.” and under the new name “PROG Holdings, Inc.”

Any Company shareholders who sell their shares in the “regular-way” market on or before November 27, 2020, will also be selling their right to receive The Aaron’s Company common stock in the distribution. Investors are encouraged to consult with their financial advisors regarding the specific implications of buying and selling Company common stock on or before the distribution date.

Trading in common stock of The Aaron’s Company is expected to begin on a “when issued” basis on or about November 25, 2020 on the New York Stock Exchange, under the symbol “AAN WI.” and under the name “The Aaron’s Company, Inc.” “When issued” trading of common stock of The Aaron’s Company will continue until the distribution occurs. The Company anticipates that “regular way” trading of common stock of The Aaron’s Company under the symbol “AAN” will begin on December 1, 2020.

On December 1, 2020, “regular-way” trading for the Company under the name “PROG Holdings, Inc.” will begin on the NYSE under the symbol “PRG.”

The distribution of The Aaron’s Company common stock is subject to the satisfaction or waiver of certain conditions including, but not limited to, the Registration Statement on Form 10 for The Aaron’s Company common stock being declared effective by the U.S. Securities and Exchange Commission, and the other conditions described in the information statement included in the Form 10.

About Aaron’s Holdings Company, Inc.

Headquartered in Atlanta, Aaron’s Holdings Company, Inc. (NYSE: AAN), is a leading omnichannel provider of lease-purchase solutions. Progressive Leasing provides lease-purchase solutions through more than 20,000 retail partner locations in 46 states and the District of Columbia, including e-commerce merchants. The Aaron’s Business engages in the sales and lease ownership and specialty retailing of furniture, home appliances, consumer electronics and accessories through its approximately 1,400 Company-operated and franchised stores in 47 states, Puerto Rico and Canada, as well as its e-commerce platform, Aarons.com. Vive Financial, provides a variety of second-look credit products that are originated through federally-insured banks. For more information, visit investor.aarons.com, Aarons.com, ProgLeasing.com, and ViveCard.com.

Forward-Looking Statements

Statement under the Private Securities Litigation Reform Act of 1995: Statements in this news release that are not historical facts are “forward-looking statements” that involve risks and uncertainties which could cause actual results to differ materially from those contained in the forward-looking statements. Such forward-looking statements generally can be identified by the use of forward-looking terminology, such as “will,” “expected,” “positioned,” and similar terminology. These risks and uncertainties include factors such as (a) uncertainties as to the timing of the separation and whether it will be completed; (b) the possibility that various closing conditions for the separation may not be satisfied; (c) failure of the separation to qualify for the expected tax treatment; (d) the risk that the Aaron’s and Progressive businesses will not be separated successfully or such separation may be more difficult, time-consuming and/or costly than expected; (e) the possibility that the operational, strategic and shareholder value creation opportunities from the separation may not be achieved; (f) the effects on our business from the COVID-19 pandemic, including its impact on our revenue and overall financial performance and the manner in which we are able to conduct our operations; (g) increases in lease merchandise write-offs and the provision for returns and uncollectible renewal payments in light of the impact of the COVID-19 pandemic; and (h) the other risks and uncertainties discussed under “Risk Factors” in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019 and in the Company’s Quarterly Report on Form 10-Q for the quarters ended March 31, 2020, June 30, 2020 and September 30, 2020 and The Aaron’s Company’s Registration Statement on Form 10, as amended, initially filed with the U.S. Securities and Exchange Commission on November 2, 2020. Statements in this press release that are “forward-looking” include without limitation statements regarding the planned separation of the Aaron’s and Progressive businesses, the timing of any such separation, the expected benefits of the separation, and the future performance of the Aaron’s and Progressive businesses if the separation is completed. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Except as required by law, the Company undertakes no obligation to update these forward-looking statements to reflect subsequent events or circumstances after the date of this press release.

View original content:http://www.prnewswire.com/news-releases/aarons-holdings-sets-record-and-closing-date-for-spin-off-of-the-aarons-business-301175413.html

SOURCE Aaron’s, Inc.

November 17, 2020 6:17 pm

Clifford Law Offices Partner Susan A. Capra Celebrates 30 Years as a Chicago Medical Malpractice Attorney

Chicago, IL, Nov. 17, 2020 (GLOBE NEWSWIRE) — Susan A. Capra, attorney and partner at Clifford Law Offices, is celebrating a milestone of 30 years as a Chicago medical malpractice attorney. Ms. Capra joined Clifford Law Offices as an associate 30 years ago. After ten years, she made partner and has worked as a partner for 20 years. Ms. Capra concentrates her law practice in medical and hospital negligence litigation.

Ms. Capra graduated from DePaul University with a nursing degree and worked largely with infants and children with serious neurological conditions and disabilities prior to becoming a lawyer. Her nursing background helps her get the necessary details about what occurred during a client’s treatment in order to effectively prosecute a medical negligence lawsuit. Ms. Capra sums it up appropriately, “As a nurse, I was the patient’s advocate. As a medical malpractice attorney, I am still the patient’s advocate but in a different arena and profession.”

Ms. Capra primarily handles cases involving obstetrical, gynecologic, and pediatric negligence cases and has obtained outstanding settlements and verdicts.

Some highlights of her career include:

$11 million settlement involving a hospital pharmacy that mixed an intravenous solution with excessive amounts of glucose, which was given to a premature newborn who then sustained severe and permanent brain damage as a result (worked in collaboration with senior partner, Robert Clifford, and partner Keith Hebeisen).
$10 million settlement on behalf of a mother whose infant suffered severe and permanent brain damage due to negligent obstetrical treatment rendered at a Chicago hospital (worked in collaboration with senior partner, Robert Clifford, and partner Keith Hebeisen).
$8.1 million settlement on behalf of a mother’s first-born infant boy who suffered serious and permanent brain damage due to negligent management of her labor and delivery (worked with partner Kevin Durkin).
$7.2 million settlement on behalf of a young boy who suffered brain damage when the obstetrician and hospital staff failed to perform a C-section delivery.
$3.2 million settlement involving the wrongful death of young mother from a post-partum hemorrhage after giving birth.

In the last decade, Ms. Capra has worked on 28 obstetrical and gynecological cases involving medical negligence. Eighteen cases have resulted in settlements and verdicts of over one million dollars and ten have resulted in settlements and verdicts over five million dollars.

Over the years, Ms. Capra has been recognized as an Illinois Leading Lawyer by Law Bulletin Media (2005 – present), selected to the Illinois Super Lawyers list (2005 to present), has an AV rating by Martindale-Hubbell, and was part of the list of Most Influential Women Lawyers in Chicago by Crain’s Custom Media (2017). Most recently in 2020, she was named by Crain’s Chicago Business on a list of Notable Women in Law in Chicago.

Congratulations Susan. It is an honor and privilege to have you on the Clifford Law Offices Team.

About Clifford Law Offices
Clifford Law Offices is ranked one of the top Chicago law firms, serving clients nationally and internationally for over 30 years. Our personal injury law firm concentrates on complex personal injury litigation such as for wrongful death, medical malpractice, product liability, premises negligence and transportation liability, and are nationally known for our success in complicated legal matters.

Attachment

Susan_Capra

Rachel Baker
Clifford Law Offices
[email protected]

November 17, 2020 6:15 pm

FirstEnergy Receives NYSE Notice Regarding Delayed Form 10-Q Filing

PR Newswire

AKRON, Ohio, Nov. 17, 2020 /PRNewswire/ — FirstEnergy Corp. (NYSE: FE) announced today that on November 17, 2020, the Company received notice from the New York Stock Exchange (NYSE) that the Company is not in compliance with the NYSE’s continued listing requirements under the timely filing criteria outlined in Section 802.01E of the NYSE Listed Company Manual because the company failed to timely file its Quarterly Report on Form 10-Q for the period ended September 30, 2020 (Form 10-Q), which was due to be filed with the Securities and Exchange Commission (SEC) no later than November 16, 2020.

FirstEnergy previously filed a Form 12b-25 with the SEC on November 9, 2020, to extend the due date for the Form 10-Q from November 9, 2020, the date on which such report was initially due, to November 16, 2020.

The NYSE notice has no immediate effect on the listing of the Company’s stock on the NYSE or on any of the Company’s outstanding bonds. The NYSE informed the Company that, under the NYSE’s rules, the Company has six months, until May 17, 2021, to file its Form 10-Q, and any subsequent delayed filings and regain compliance with the NYSE listing standards. The Company intends to become current in its SEC reporting obligations as soon as possible.

During the course of the Company’s internal investigation related to ongoing government investigations, the existence of which was previously disclosed in the Company’s Form 10-Q for the period ended June 30, 2020, the Independent Review Committee of the Board of Directors of the Company (the Committee) determined that three executives, including the Company’s former Chief Executive Officer, violated certain Company policies and its code of conduct and should be terminated. The terminations were effective October 29, 2020. Following the Committee’s determination regarding these violations of certain Company policies and its code of conduct, the Company is re-evaluating its controls framework, which could include identifying one or more material weaknesses. Further, the internal investigation remains ongoing.

In connection with the ongoing government investigations and the Company’s re-evaluation of its controls framework, which could include identifying one or more material weaknesses, the Company requires additional time to complete its quarterly review and closing procedures and to provide appropriate disclosure in the Form 10-Q.

FirstEnergy is dedicated to safety, reliability and operational excellence. Its 10 electric distribution companies form one of the nation’s largest investor-owned electric systems, serving customers in Ohio, Pennsylvania, New Jersey, West Virginia, Maryland and New York. The company’s transmission subsidiaries operate approximately 24,500 miles of transmission lines that connect the Midwest and Mid-Atlantic regions. Follow FirstEnergy on Twitter @FirstEnergyCorp or online at www.firstenergycorp.com.

Forward-Looking Statements:
This news release includes forward-looking statements based on information currently available to management. Such statements are subject to certain risks and uncertainties and readers are cautioned not to place undue reliance on these forward-looking statements. These statements include declarations regarding management’s intents, beliefs and current expectations. These statements typically contain, but are not limited to, the terms “anticipate,” “potential,” “expect,” “forecast,” “target,” “will,” “intend,” “believe,” “project,” “estimate,” “plan” and similar words. Forward-looking statements involve estimates, assumptions, known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements, which may include the following: our ability to become current in our SEC reporting obligations; the results of our ongoing internal investigation and evaluation of our controls framework, the extent and duration of COVID-19 and the impacts to our business, operations and financial condition resulting from the outbreak of COVID-19 including, but not limited to, disruption of businesses in our territories, volatile capital and credit markets, legislative and regulatory actions, the effectiveness of our pandemic and business continuity plans, the precautionary measures we are taking on behalf of our customers, contractors and employees, our customers’ ability to make their utility payment and the potential for supply-chain disruptions; the risks and uncertainties associated with government investigations regarding Ohio House Bill 6 and related matters including potential adverse impacts on federal or state regulatory matters including, but not limited to, matters relating to rates; the risks and uncertainties associated with litigation, arbitration, mediation and similar proceedings; legislative and regulatory developments, including, but not limited to, matters related to rates, compliance and enforcement activity; mitigating exposure for remedial activities associated with retired and formerly owned electric generation assets, including, but not limited to, risks associated with the decommissioning of TMI-2; the ability to accomplish or realize anticipated benefits from strategic and financial goals, including, but not limited to, executing our transmission and distribution investment plans, controlling costs, improving our credit metrics, strengthening our balance sheet and growing earnings and maintaining financial flexibility; economic and weather conditions affecting future operating results, such as a recession, significant weather events and other natural disasters, and associated regulatory events or actions in response to such conditions; changes in assumptions regarding economic conditions within our territories, the reliability of our transmission and distribution system, or the availability of capital or other resources supporting identified transmission and distribution investment opportunities; changes in customers’ demand for power, including, but not limited to, the impact of climate change or energy efficiency and peak demand reduction mandates; changes in national and regional economic conditions affecting us and/or our major industrial and commercial customers or others with which we do business; the risks associated with cyber-attacks and other disruptions to our information technology system, which may compromise our operations, and data security breaches of sensitive data, intellectual property and proprietary or personally identifiable information; the ability to comply with applicable reliability standards and energy efficiency and peak demand reduction mandates; changes to environmental laws and regulations, including, but not limited to, those related to climate change; changing market conditions affecting the measurement of certain liabilities and the value of assets held in our pension trusts and other trust funds, or causing us to make contributions sooner, or in amounts that are larger, than currently anticipated; labor disruptions by our unionized workforce; changes to significant accounting policies; any changes in tax laws or regulations, or adverse tax audit results or rulings; the ability to access the public securities and other capital and credit markets in accordance with our financial plans, the cost of such capital and overall condition of the capital and credit markets affecting us, including the increasing number of financial institutions evaluating the impact of climate change on their investment decisions; actions that may be taken by credit rating agencies that could negatively affect either our access to or terms of financing or our financial condition and liquidity; and the risks and other factors discussed from time to time in our SEC filings. Dividends declared from time to time on FirstEnergy Corp.’s common stock during any period may in the aggregate vary from prior periods due to circumstances considered by FirstEnergy Corp.’s Board of Directors at the time of the actual declarations. A security rating is not a recommendation to buy or hold securities and is subject to revision or withdrawal at any time by the assigning rating agency. Each rating should be evaluated independently of any other rating. The foregoing factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements and risks that are included in our filings with the SEC, including but not limited to the most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The foregoing review of factors also should not be construed as exhaustive. New factors emerge from time to time, and it is not possible for management to predict all such factors, nor assess the impact of any such factor on FirstEnergy Corp.’s business or the extent to which any factor, or combination of factors, may cause results to differ materially from those contained in any forward-looking statements. FirstEnergy expressly disclaims any current intention to update or revise, except as required by law, any forward-looking statements contained herein as a result of new information, future events or otherwise.

View original content to download multimedia:http://www.prnewswire.com/news-releases/firstenergy-receives-nyse-notice-regarding-delayed-form-10-q-filing-301175406.html

SOURCE FirstEnergy Corp.

November 17, 2020 6:09 pm

Third Phase of Benefitfocus’ “Open Enrollment Success in the Era of COVID” Offers Guidance on Evaluating OE Effectiveness

Benefits administrators can review best practices and reference documents for determining OE success and challenges

PR Newswire

CHARLESTON, S.C., Nov. 17, 2020 /PRNewswire/ — Benefitfocus, Inc. (NASDAQ: BNFT), an industry-leading benefits technology platform that simplifies benefits administration for employers, health plans and brokers, today launched the third phase of “Open Enrollment Success in the Era of COVID,” a six-week, three-phase educational series to support benefits administrators during the 2020 Open Enrollment period.

In this phase, users of Benefitfocus’ Resource Center can access material to enable them to objectively evaluate the results of this year’s open enrollment campaigns.

“This educational series has been designed to enable us to use our role as a valued resource and partner to help benefits leaders through all phases of this year’s open enrollment season,” said Annmarie Fini, Executive Vice President, Customer Success Organization, Benefitfocus. “While this year has been unique due to the impact of COVID-19, it is still possible and in fact crucial to properly and thoroughly evaluate open enrollment effectiveness and apply that analysis to create an even more successful campaign next year.”

Some of the items in the Resource Center that are most relevant to the need for effective evaluation of Open Enrollment are:

Open Enrollment Metrics Report Template: This post-open enrollment executive debrief template helps administrators compile and present a comprehensive view on open enrollment metrics.
Open Enrollment Scorecard: This artifact enables users to evaluate their open enrollment campaign in four categories: planning, communication, execution and aftermath. The total score will help determine the direction to take to improve that performance next year.
Scoring Your Open Enrollment: This shared expertise provides greater insight into the use of the Open Enrollment Scorecard, and how best to use its four categories to get an accurate read on how this year’s Open Enrollment campaign went, as well as clear direction on how to make next year’s enrollment the best yet.

The program has provided insight in three phases: the final days and weeks before open enrollment, open enrollment itself and the period immediately following open enrollment. Benefitfocus is providing a range of materials from the extensive library in its Resource Center, including webinars, blog posts, white papers, templates and reference guides. These best practices have been developed based on the knowledge acquired through serving thousands of employer open enrollment events and millions of employee user sessions.

Benefitfocus Resource Center
As a leader in health claims data integration and analysis, Benefitfocus offers a Resource Center that provides useful resources, information and inspiration for everyone in the benefits ecosystem to successfully drive change across the industry. In 2020, the Resource Center expanded to provide relevant information regarding COVID-19, including government data, proprietary information, communications tactics and tools, a community forum, and access to third-party sources.

Benefitfocus provides this unique utility within its platform as a means of enabling customers to benefit from the broadest field of vision regarding benefits activity.

Connect with Benefitfocus
Benefitfocus customers should contact their Customer Service Manager for further assistance and insight to drive open enrollment success.
To see the full range of resources regarding open enrollment, click here.
Like Benefitfocus on Facebook: https://www.facebook.com/Benefitfocus
Follow @benefitfocus on Twitter
Follow Benefitfocus on LinkedIn
Follow Benefitfocus on Instagram

About Benefitfocus
Benefitfocus (NASDAQ: BNFT) unifies the entire U.S. benefits industry on a single technology platform to protect consumers for life. Our powerful cloud-based software, data-driven insights and thoughtfully-designed services enable employers, insurance brokers, health plans and suppliers to simplify the complexity of benefits administration and deliver health, wealth, property and lifestyle products through a world-class benefits experience. Learn more at www.benefitfocus.com, LinkedIn and Twitter.

Except for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements. Actual results or performance might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially
include: volatility and uncertainty in the global economy and financial markets in light of the evolving COVID-19 pandemic; the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; the immature and volatile nature of the market for our products and services; our ability to compete effectively; our ability to maintain our culture and recruit and retain qualified personnel; privacy; security and other risks associated with our business; management of growth; and the other risk factors set forth from time to time in our SEC filings, copies of which are available free of charge within the Investor Relations section of the Benefitfocus website at http://investor.benefitfocus.com/sec-filings or upon request from our investor relations department. Benefitfocus assumes no obligation and does not intend to update these forward-looking statements, except as required by law.

The views expressed by non-Benefitfocus employees as speakers in presentations made at One Place events are those of the speaker and not, necessarily, of Benefitfocus. Presentations at One Place events, or the presence of vendors or sponsorships at One Place events, does not constitute an endorsement of the vendor or speaker’s views, products or services and are provided for educational purposes only.

View original content:http://www.prnewswire.com/news-releases/third-phase-of-benefitfocus-open-enrollment-success-in-the-era-of-covid-offers-guidance-on-evaluating-oe-effectiveness-301175405.html

SOURCE Benefitfocus, Inc.

November 17, 2020 6:08 pm

WOW Unlimited Media Inc. Announces Closing of First Tranche of Non-brokered Private Placement of Unsecured Convertible Debentures

VANCOUVER, British Columbia, Nov. 17, 2020 (GLOBE NEWSWIRE) — WOW Unlimited Media Inc. (“WOW!” or the “Company”) (TSXV:WOW; OTCQX: WOWMF) is pleased to announce that it has closed the first tranche (the “First Tranche Closing”) of its previously announced non-brokered private placement offering of unsecured subordinated convertible debentures (the “Debentures”) for gross proceeds of $2,639,000. WOW has also received irrevocable subscriptions for an additional $2,061,000, for a total offering size of $4,700,000 (the “Offering”), representing a $200,000 upsize due to increased demand since the Company’s first announcement of the Offering on October 28, 2020.

Pursuant to the First Tranche Closing, WOW! issued 2,639 Debentures at an issue price of $1,000 per $1,000 principal amount of Debentures.

The Debentures were issued pursuant to the terms of a debenture indenture entered into between the WOW! and Computershare Trust Company of Canada (the “Debenture Indenture“) and will mature on the date that is 36 months from the issuance date. Each Debenture bears interest at a rate of 9.5% per annum from the date of issue, payable in equal quarterly payments on March 31, June 30, September 30 and December 31 in each year commencing December 31, 2020.

Pursuant to the terms of the Debenture Indenture, each Debenture is convertible, at the option of the holder, into common shares of the Company (“Shares”) at any time prior to the close of business on the earlier of: (i) the last business day immediately preceding the maturity date; and (ii) the date fixed for redemption, at a conversion price of $0.55 per Share. The Debentures will be subordinated to the senior indebtedness of the Company; however, the Debentures will rank pari passu with each other series of debentures issued under the Debenture Indenture or under indentures supplemental to the Debenture Indenture (regardless of their actual date or terms of issue) and, except as prescribed by law, with all other existing and future unsecured indebtedness of the Company other than senior indebtedness. The Debentures are redeemable at any time after 12 months from the date of issuance at a redemption price equal to the principal amount of the Debentures plus accrued and unpaid interest thereon.

The Company has received irrevocable subscriptions for 2,061 Debentures to be issued pursuant to the second tranche of the Offering (the “Second Tranche”), the closing of which the Company anticipates to be completed immediately following the maturity of the Existing Debentures (as defined herein). The investors subscribing for Debentures in the Second Tranche are fully comprised of holders of the Company’s existing convertible debentures which mature on December 14, 2020 (the “Existing Debentures”). Holders of Existing Debentures who participate in the Second Tranche may set-off any amounts to which they are entitled on the maturity date of the Existing Debentures against amounts otherwise payable in connection with their subscription for Debentures under the Offering.

The net proceeds from both the First Tranche Closing and the Second Tranche will be used first, to pay down the Existing Debentures of $4,300,000; and secondly, for general working capital purposes.

In connection with the First Tranche Closing, the Company will pay aggregate finders’ fees of $10,000.

Related Party Transactions

The Offering constitutes a “related party transaction” within the meaning of TSX Venture Exchange (the “TSXV”) Policy 5.9 and Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101”) as certain insiders of the Company subscribed for an aggregate of $446,000 principal amount of Debentures under the First Tranche Closing and have agreed to subscribe for an aggregate $1,161,000 principal amount of Debentures under the Second Tranche. The Company has relied on exemptions from the formal valuation and minority shareholder approval requirements of MI 61-101 contained in sections 5.5(a) and 5.7(1)(a) thereof in respect of related party participation in the Offering as neither the fair market value (as determined under MI 61-101) of the subject matter of, nor the fair market value of the consideration for, the Offering, insofar as it involves related parties, is more than 25% of the Company’s market capitalization (as determined under MI 61-101). The Company did not file a material change report in respect of the related party transaction at least 21 days prior to the First Tranche Closing as participation of the insiders had not been confirmed at that time. Directors of the Company who participated in the Offering, were required to disclose their interest in the Offering and abstain from voting on the approval of the Offering.

The Offering remains subject to customary conditions, including but not limited to the final approval of the TSX Venture Exchange (“TSXV”), and the securities issued pursuant to the Offering will be subject to a statutory hold period expiring four months and one day from the First Tranche Closing and Second Tranche closing, as applicable, pursuant to applicable Canadian securities laws.

This press release does not constitute an offer of securities for sale in the United States or to “U.S. persons” as such term is defined in Regulation S promulgated under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”). The Company does not intend to register the securities being offered under the U.S. Securities Act or applicable state securities laws, and securities may not be offered or sold to persons in the United States absent registration or an exemption from such registration requirements. Any public offering of securities to be made in the United States will be made by means of a prospectus that may be obtained from the issuer or the selling security holder and that will contain detailed information about the Company and management, as well as financial statements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.

About
WOW!

WOW! is creating a leading animation-focused entertainment company by producing top-end content and building brands and audiences on engaging media platforms. The Company produces animation in its two established studios: Mainframe Studios in Vancouver and Frederator Studios in Los Angeles. The Company’s media offerings include Channel Frederator Network on YouTube, as well as WOW! branded programming on Crave, Canada’s premier streaming entertainment platform, owned by Bell Media. The common voting shares of the Company and variable voting shares of the Company are listed on the TSXV (TSXV: WOW) and the OTCQX Best Market (OTCQX: WOWMF).

Forward-Looking Statements:

This press release contains certain forward-looking statements and forward-looking information (collectively referred to herein as “forward-looking statements”) within the meaning of applicable Canadian securities laws. All statements other than statements of present or historical fact are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “anticipate”, “achieve”, “could”, “believe”, “plan”, “intend”, “objective”, “continuous”, “ongoing”, “estimate”, “outlook”, “expect”, “may”, “will”, “project”, “should” or similar words, including negatives thereof, suggesting future outcomes.

In particular, this press release contains forward-looking statements relating to, among other things: the size of the Offering, the anticipated Second Tranche closing date and the intended use of the net proceeds of the Offering. Such statements reflect management’s current views with respect to future events and are subject to risks and uncertainties and are necessarily based upon a number of estimates and assumptions that, while considered reasonable by WOW!, are inherently subject to significant business, economic, competitive, political and social uncertainties and contingencies. Many factors could cause our actual results, performance or achievements to be materially different from any future results, performance, or achievements that may be expressed or implied by such forward-looking statements. In making the forward-looking statements included in this press release, the Company has made various material assumptions, including, but not limited to general business and economic conditions; the Company’s ability to raise additional funding; capital expenditure programs and other expenditures by the Company and its customers; existing governmental regulations and changes in, or the failure to comply with, governmental regulations; and changes in business strategy or development plans.

Forward-looking statements are not a guarantee of future performance and are subject to and involve a number of known and unknown risks and uncertainties, many of which are beyond the control of the Company, which may cause the Company’s actual performance and results to differ materially from any projections of future performance or results expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, the risks identified in the Company’s Management’s Discussion and Analysis for its year ended December 31, 2019, which has been filed with the Canadian Securities Administrators and is available on the System for Electronic Document Analysis and Retrieval at www.sedar.com. Any forward-looking statements are made as of the date hereof and, except as required by law, the Company assumes no obligation to publicly update or revise such statements to reflect new information, subsequent or otherwise.

Neither
the TSXV
nor its Regulation Services Provider (as that term is defined in the policies of the
TSXV
) accepts responsibility for the adequacy or accuracy of this
press
release.

Further information available at:

Website: www.wowunlimited.co
Contact: Bill Mitoulas, Investor Relations
Tel: (416) 479-9547
Email: [email protected]

November 17, 2020 6:03 pm

/U P D A T E — Eaton Vance Corp./

PR Newswire

In the news release, “Eaton Vance Corp. Fourth Fiscal Quarter and Fiscal Year Ended 2020 Earnings Conference Call and Webcast Notification”, issued 17-Nov-2020 by Eaton Vance Corp. over PR Newswire, we were advised by the company of the following update, as follows:

UPDATE: Eaton Vance Corp. Fourth Fiscal Quarter and Fiscal Year 2020 Earnings

BOSTON, Nov. 17, 2020 /PRNewswire/ — Eaton Vance Corp. (NYSE: EV) will release fourth fiscal quarter and fiscal year 2020 earnings at approximately 9:00 AM ET on Tuesday, November 24, 2020. The full earnings release and accompanying details illustrating key performance measures will be available on Eaton Vance’s website, eatonvance.com, under “investor relations.”

Eaton Vance Corp. provides advanced investment strategies and wealth management solutions to forward-thinking investors around the world. Through principal investment affiliates Eaton Vance Management, Parametric, Atlanta Capital, Calvert and Hexavest, the Company offers a diversity of investment approaches, encompassing bottom-up and top-down fundamental active management, responsible investing, systematic investing and customized implementation of client-specified portfolio exposures. As of September 30, 2020, Eaton Vance had consolidated assets under management of $517.0 billion. Exemplary service, timely innovation and attractive returns across market cycles have been hallmarks of Eaton Vance since 1924. For more information, visit eatonvance.com.

View original content:http://www.prnewswire.com/news-releases/eaton-vance-corp-fourth-fiscal-quarter-and-fiscal-year-ended-2020-earnings-conference-call-and-webcast-notification-301174852.html

SOURCE Eaton Vance Corp.

November 17, 2020 6:03 pm

Canfor Signs Agreement with Peak Renewables to Sell Fort Nelson Tenure

Canada NewsWire

VANCOUVER, BC, Nov. 17, 2020 /CNW/ – Canfor announced today it has reached multi-year $30-million agreements with Peak Renewables involving the sale of the Company’s forest tenure in the Fort Nelson region of British Columbia. The transactions are subject to customary closing conditions, including approval from the BC Minister of Forests. Closing is expected to occur in the first quarter of 2021.

The agreements follow Peak Renewables’ purchase of Canfor’s Fort Nelson mill assets in the third quarter of 2020.

“I am pleased to have reached an agreement to sell our Fort Nelson tenure to Peak Renewables, a company that is committed to developing a long term plan to rejuvenate the forest industry in the region,” said Don Kayne, President and CEO, Canfor.

Forward Looking Statements
Certain statements in this press release constitute “forward-looking statements” which involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. Words such as “expects”, “anticipates”, “projects”, “intends”, “plans”, “will”, “believes”, “seeks”, “estimates”, “should”, “may”, “could”, and variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are based on management’s current expectations and beliefs and actual events or results may differ materially. There are many factors that could cause such actual events or results expressed or implied by such forward-looking statements to differ materially from any future results expressed or implied by such statements. Forward-looking statements are based on current expectations and Canfor assumes no obligation to update such information to reflect later events or developments, except as required by law.

Canfor is a leading integrated forest products company based in Vancouver, British Columbia (“BC”) with interests in BC, Alberta, North and South Carolina, Alabama,

Georgia, Mississippi and Arkansas, as well as in Sweden with its majority acquisition of Vida Group
. Canfor produces primarily softwood lumber and also owns a 54.8% interest in Canfor Pulp Products Inc., which is one of the largest global producers of market Northern Bleached Softwood Kraft Pulp and a leading producer of high performance kraft paper. Canfor shares are traded on The Toronto Stock Exchange under the symbol CFP. For more information visit

canfor.com

.

SOURCE Canfor Corporation

November 17, 2020 5:56 pm

ROSEN, A LEADING LAW FIRM, Announces Investigation of Securities Claims Against Alphabet Inc.; Encourages Investors with Losses in Excess of $100K to Contact the Firm – GOOG, GOOGL

PR Newswire

NEW YORK, Nov. 17, 2020 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Alphabet Inc. (NASDAQ: GOOG, GOOGL) resulting from allegations that Alphabet may have issued materially misleading business information to the investing public.

On June 1, 2019, the Wall Street Journal reported that “[t]he Justice Department is gearing up for an antitrust investigation of Alphabet Inc.’s Google, a move that could present a major new layer of regulatory scrutiny for the search giant, according to people familiar with the matter.”

On this news, Alphabet’s Class A common stock price fell $67.76 per share, or over 6%, to close at $1,038.74 per share on June 3, 2019, the next trading day.

Then on October 20, 2020, the U.S. Department of Justice filed an antitrust lawsuit against Google, LLC, a subsidiary of Alphabet.

Rosen Law Firm is preparing a securities lawsuit on behalf of Alphabet shareholders. If you purchased securities of Alphabet please visit the firm’s website at http://www.rosenlegal.com/cases-register-1984.html to join the securities action. You may also contact Phillip Kim of Rosen Law Firm toll free at 866-767-3653 or via email at mailto:[email protected] or [email protected].

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm’s attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors. Attorney Advertising. Prior results do not guarantee a similar outcome.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 40^th Floor
      New York, NY 10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      [email protected]
      [email protected]
      [email protected]
      www.rosenlegal.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/rosen-a-leading-law-firm-announces-investigation-of-securities-claims-against-alphabet-inc-encourages-investors-with-losses-in-excess-of-100k-to-contact-the-firm–goog-googl-301175306.html

SOURCE Rosen Law Firm, P.A.

November 17, 2020 5:56 pm

Immunome Reports Third Quarter 2020 Financial Results and Significant Progress

Immunome Reports Third Quarter 2020 Financial Results and Significant Progress

– Completed $44.9M IPO in October –

– Identified COVID 19 Neutralizing antibodies –

– Significant progress made on lead programs, including IMM-BCP-01 for the treatment of COVID-19 in collaboration with US Department of Defense –

EXTON, Pa.–(BUSINESS WIRE)–
Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics, with a focus on oncology and infectious diseases including COVID-19, today announced third quarter 2020 financial results and recent highlights.

“The completion of our recent IPO marks a significant milestone for Immunome and positions us to further accelerate the output of new discoveries from our platform, and to rapidly advance our lead oncology and COVID-19 therapeutic antibody programs into the clinic,” said Purnanand Sarma, PhD, President and CEO of Immunome. “We are on track to execute on our near-term clinical and strategic plans, including filing IND applications for two of our programs in 2021.” Dr. Sarma further stated, “I am proud of the tremendous progress our team has made this year, particularly with regard to the notable effort and dedication supporting our accelerated development of antibody-based treatment targeting multiple viral antigens to treat the COVID-19 virus. As previously announced, Immunome was awarded a $13.3 million contract from the US Department of Defense to develop an antibody cocktail discovered by the interrogation of memory B cells from ‘super-responders’ to the SARS-CoV-2 virus (DoD Press Release).”

Recent Highlights

In October 2020, Immunome completed an IPO, including the full exercise of the underwriters’ option to purchase additional shares, resulting in gross proceeds of $44.9 million, before deducting underwriting commissions and offering expenses.
IMM-BCP-01: Unlike approaches solely directed at neutralizing the Spike protein by other companies, we aim to develop an antibody cocktail directed at multiple SARS-CoV-2 antigens. Unbiased interrogation of SARS-CoV-2 “super-responder” memory B cells using Immunome’s discovery engine has resulted in the following advances:
- We discovered that more than 50% of the antibodies isolated from super-responders are directed at non-Spike antigens, suggesting non-Spike related antibodies may play a significant role in the effective immunological clearance of this virus.
- We also identified multiple neutralizing antibodies with picomolar affinity directed at SARS-CoV-2 Spike protein.
- We discovered that, in addition to affinity matured IgG antibodies, COVID-19 “super-responders” appear to mount robust affinity-matured IgA responses. IgA antibodies are naturally found at the surface of respiratory track and function to prevent initial viral infection.
IMM-ONC-01: Our further pre-clinical testing continues to demonstrate that IL-38 appears to be a novel immune checkpoint. In animal models, our inhibitory antibody demonstrates antitumor effects in IL-38 expressing tumors.

Third Quarter 2020 Financial Results:

Cash and cash equivalents: Cash and cash equivalents were $6.7 million as of September 30, 2020 compared to $2.5 million as of December 31, 2019.
IPO and net proceeds: On October 2, 2020 the Company’s common stock began trading on the Nasdaq Capital Market under the ticker (IMNM) and on October 6, 2020 the IPO closed with the Company receiving net proceeds of $41.7 million, after deducting underwriting discounts but before deducting other offering expenses. After deducting other offering costs of approximately $2.8 million, aggregate net IPO proceeds to the Company were $38.9 million.
Research and development (R&D) expenses: R&D expenses were $1.6 million for the quarter ended September 30, 2020 compared to $2.2 million for the quarter ended September 30, 2019 and $5.7 million for the nine month period ended September 30, 2020 compared to $6.4 million for the nine month period ended September 30, 2019.
General and administrative (G&A) expenses: G&A expenses were $1.2 million for the quarter ended September 30, 2020 compared to $0.5 million for the quarter ended September 30, 2019 and $2.5 million for the nine month period ended September 30, 2020 compared to $1.1 million for the nine month period ended September 30, 2019.
Net loss: Net loss attributable to common stockholders was $8.4 million or $7.52 per share for the quarter ended September 30, 2020 compared to $2.7 million or $2.50 per share for the quarter ended September 30, 2019 and $13.8 million or $12.44 per share for the nine month period ended September 30, 2020 compared to $7.5 million or $6.88 per share for the nine month period ended September 30, 2019.

About Immunome, Inc.

Immunome is a biopharmaceutical company utilizing our proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. Immunome’s proprietary discovery platform identifies novel therapeutic antibodies and their targets by leveraging highly educated components of the immune system, memory B cells, from patients whose bodies have learned to fight off their disease.

Forward-Looking Statements

This press release includes certain disclosures that contain “forward-looking statements” intended to qualify for the “safe harbor” from liability established by the Private Securities Litigation Reform Act of 1995, as amended, including, without limitation, express or implied statements regarding Immunome’s beliefs and expectations regarding the advancement of its oncology and COVID-19 therapeutic antibody programs, execution of its clinical and strategic plans, anticipated upcoming milestones for IMM-BCP-01 and IMM‐ONC‐01, including expectations regarding therapeutic potential and benefits thereof, and IND filings. Forward-looking statements may be identified by the words “anticipate,” believe,” “estimate,” “expect,” “intend,” “plan,” “project,” “may,” “will,” “could,” “should,” “seek” and similar expressions. Forward-looking statements are based on Immunome’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Factors that could cause actual results to differ include, but are not limited to, those risks and uncertainties associated with: the impact of the COVID-19 pandemic on Immunome’s business, operations, strategy, goals and anticipated milestones, Immunome’s ability to execute on its strategy including with respect to the timing of IND filings, Immunome’s ability to fund operations, as well as those risks and uncertainties set forth more fully under the caption “Risk Factors” in the final prospectus dated October 1, 2020 and filed pursuant to Rule 424(b) under the Securities Act of 1933, as amended, with the United States Securities and Exchange Commission (SEC) and elsewhere in Immunome’s filings and reports with the SEC. Forward-looking statements contained in this announcement are made as of this date, and Immunome undertakes no duty to publicly update or revise any forward looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable law.


IMMUNOME, INC.
Condensed Balance Sheets
(Unaudited; In thousands, except share and per share data)

	September 30, 2020		December 31, 2019
Assets
Current assets:
Cash	$	6,744	$	2,543
Prepaid expenses and other current assets		739		579
Total current assets		7,483		3,122
Property and equipment, net		1,741		1,700
Restricted cash		100		100
Other assets		2,659		138
Total assets	$	11,983	$	5,060
Liabilities, convertible preferred stock, and stockholders’ deficit
Current liabilities:
Current portion of capital lease obligations	$	—	$	239
Current portion of equipment loan payable		144		212
Current portion of long-term debt		305		—
Accounts payable		2,627		548
Accrued expenses and other current liabilities		2,330		666
Total current liabilities		5,406		1,665
Equipment loan payable, net of current portion		16		113
Long-term debt, net of current portion		195		—
Warrant liability		7,071		—
Deferred rent		11		18
Total liabilities		12,699		1,796

Series A convertible preferred stock, $0.0001 par value; 45,000,000 and 30,000,000 shares authorized and 5,670,184 and 4,443,259 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively (liquidation value of $51,033 at September 30, 2020)		48,369		38,894
Stockholders’ deficit:
Common stock, $0.0001 par value; 65,000,000 and 50,000,000 shares authorized and 1,124,616 and 1,099,270 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively		—		—
Additional paid-in capital		1,236		927
Accumulated deficit		(50,321)		(36,557)
Total stockholders’ deficit		(49,085)		(35,630)
Total liabilities, convertible preferred stock, and stockholders’ deficit	$	11,983	$	5,060


IMMUNOME, INC.
Condensed Statements of Operations
(Unaudited; In thousands, except share and per share data)

	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019

Operating expenses:
Research and development	$	1,644	$	2,234	$	5,651	$	6,391
General and administrative		1,174		486		2,537		1,069
Total operating expenses		2,818		2,720		8,188		7,460
Loss from operations		(2,818)		(2,720)		(8,188)		(7,460)
Other expenses:
Change in fair value of warrant liability		(5,549)		—		(5,549)		—
Interest expense, net		(10)		(17)		(27)		(62)
Total other expenses		(5,559)		(17)		(5,576)		(62)
Net loss	$	(8,377)	$	(2,737)	$	(13,764)	$	(7,522)
Per share information:
Net loss per share of common stock, basic and diluted	$	(7.52)	$	(2.50)	$	(12.44)	$	(6.88)
Weighted-average common shares outstanding, basic and diluted		1,114,427		1,093,028		1,106,039		1,092,630

View source version on businesswire.com: https://www.businesswire.com/news/home/20201117006292/en/

Investor Contact:

Richard F. Fitzgerald

Chief Financial Officer

Immunome, Inc.

[email protected]

Media Contact:

Nicholas Chang

MacDougall

781-235-3060

[email protected]

KEYWORDS: Pennsylvania United States North America

INDUSTRY KEYWORDS: Oncology Health Infectious Diseases Clinical Trials Pharmaceutical Biotechnology

MEDIA:

Logo

November 17, 2020 5:52 pm

ROSEN, A LEADING LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Wells Fargo & Company; Encourages Investors with Losses in Excess of $100K to Contact the Firm – WFC

PR Newswire

NEW YORK, Nov. 17, 2020 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Wells Fargo & Company (NYSE: WFC) between October 13, 2017 and October 13, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Wells Fargo investors under the federal securities laws.

To join the Wells Fargo class action, go to http://www.rosenlegal.com/cases-register-1985.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Wells Fargo had systematically failed to follow appropriate underwriting standards and due diligence guidelines in issuing billions of dollars’ worth of commercial loans, including by inflating the net income and future expected cash flows of its commercial clients to justify issuing excessive loan amounts; (2) a materially higher proportion of Wells Fargo’s commercial loan customers were of poor credit quality and/or at a substantially higher risk of default than disclosed to investors; (3) Wells Fargo had failed to timely write down commercial loans, collateralized loan obligations (“CLOs”) and commercial mortgage backed securities (“CMBS”) on its books that had suffered impairments; (4) Wells Fargo had materially understated the reserves needed for expected credit losses in its commercial portfolios; (5) Wells Fargo had systematically misrepresented the credit quality and likelihood of default of the loans it packaged and securitized into CLOs and CMBS, including by artificially inflating the net income and expected cash flows of its commercial clients in loan and securitization documentation; (6) the CLO and CMBS-related loans issued and investment securities held by Wells Fargo were of lower credit quality and worth far less than represented to investors; (7) as a result of the foregoing, Wells Fargo’s Class Period statements regarding the credit quality of its commercial loans, its underwriting and due diligence practices, and the value of its CLO and CMBS books were materially false and misleading and (8) as a result of the foregoing, Wells Fargo was exposed to severe undisclosed risks of financial, reputational and legal harm, in particular in the event of significant and sustained stress in the commercial credit markets. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 29, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-register-1985.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at [email protected] or [email protected].

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. AN INVESTOR’S ABILITY TO SHARE IN ANY POTENTIAL FUTURE RECOVERY IS NOT DEPENDENT UPON SERVING AS LEAD PLAINTIFF.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Contact Information:

      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 40th Floor
      New York, NY 10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      [email protected]
      [email protected]
      [email protected]
      www.rosenlegal.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/rosen-a-leading-law-firm-announces-filing-of-securities-class-action-lawsuit-against-wells-fargo–company-encourages-investors-with-losses-in-excess-of-100k-to-contact-the-firm–wfc-301175305.html

SOURCE Rosen Law Firm, P.A.